13 research outputs found
Double Cation−π Directed Two-Dimensional Metallacycle-Based Hierarchical Self-Assemblies for Dual-Mode Catalysis
Hierarchical self-assembly of Pt(II)
metallacycles for
the construction
of functional materials has received considerable research interest,
owing to their potential to meet increasing complexity and functionality
demands while being based on well-defined scaffolds. However, the
fabrication of long-range-ordered Pt(II) metallacycle-based two-dimensional
hierarchical self-assemblies (2D HSAs) remains a challenge, primarily
because of the limitations of conventional orthogonal noncovalent
interaction (NCI) motifs and the intrinsic characteristics of Pt(II)
metallacycles, making the delicate self-assembly processes difficult
to control. Herein, we prepare well-regulated Pt(II)-metallacycle-based
2D HSAs through a directed strategy involving double cation−π
interactions derived from C3-symmetric
hexagonal Pt(II) metallacycles and C2-symmetric
sodium phenate monomers. Spatially confined arrays of planar Pt(II)
metallacycles and the selective growth of self-assemblies at desired
locations are achieved by employing strong cation−π driving
forces with well-defined directionality as the second orthogonal NCI,
realizing the bottom-up, three-stage construction of Pt(II)-metallacycle-based
2D HSAs. The resultant 2D HSAs are applied as dual-mode catalysis
platforms, which are loaded with two different nanocatalysts, one
promoting catalytic oxidation and the other promoting photocatalytic
reduction
Self-Assembly of a CsCl-like 3D Supramolecular Network from [Zn<sub>6</sub>(HL)<sub>6</sub>(H<sub>2</sub>L)<sub>6</sub>]<sup>6+</sup> Metallamacrocycles and (H<sub>2</sub>O)<sub>20</sub> Clusters (H<sub>2</sub>L = 4-(2-Pyridyl)-6-(4-pyridyl)-2-aminopyrimidine)
The reaction of Zn(NO3)2·6H2O with multifunctional ligand 4-(2-pyridyl)-6-(4-pyridyl)-2-aminopyrimidine (H2L) leads to a circular hexanuclear zinc complex [Zn6(HL)6(H2L)6](NO3)6·26H2O (1), confirmed by single-crystal X-ray diffraction. In the [Zn6(HL)6(H2L)6]6+ cation, six zinc centers are arranged in a chairlike conformation and 12 ligands fulfill bridging and terminal functions, respectively. The particular interest of complex 1 is the formation of a unique water cluster (H2O)26 composed of a clathrate (H2O)20 core and six dangling water molecules, and the clathrate (H2O)20 core is structurally similar to the famous “Bucky water” (H2O)20. Furthermore, the water molecules and the nitrate ions are assembled into an interesting negative three-dimensional (3D) framework through hydrogen bonds, and the [Zn6(HL)6(H2L)6]6+ cations just locate in the cavities of the anionic 3D network. To gain insight into the stability of (H2O)20 observed in complex 1, we isolate the water cluster from its environments and compare its stability with “Bucky water” (H2O)20 by a theoretical calculation method. Complex 1 displays room temperature photoluminescence
Hexaniobate as a Recyclable Solid Base Catalyst to Activate C–H Bonds in Lignin Linkage Boosting the Production of Aromatic Monomers
The targeting cleavage of lignin into value-added aromatic
monomers
has attracted increasing attention. Although the base-catalyzed depolymerization
of lignin has been developed, the use of excess corrosive bases and
their poor recyclability limit their industrial implementation. Herein,
a catalytic amount of solid base K7HNb6O19 (KNb6) coupled with copper-modified graphitic
carbon nitride (Cu/C3N4) shows enhanced catalytic
performance for the oxidative cleavage of β-O-4 lignin linkages
using molecular oxygen. Due to the synergetic effect between KNb6 and Cu/C3N4, 96% of the β-O-4
ketone model was converted under relatively mild conditions, and phenol
(yield: 90%) and other aromatic monomers (yield: 90%) were obtained.
Moreover, KNb6–Cu/C3N4 is
robust, and its catalytic activity is basically maintained after five
cycles. Experimental and theoretical studies (spectroscopic analysis,
control experiments, kinetic study, density functional theory calculations,
etc.) reveal that the surface basic O atoms of KNb6 can
simultaneously activate the Cβ–H bond of β-O-4
ketone to promote the insertion of molecular oxygen, and subsequently,
Cu/C3N4 catalyzes the selective cleavage of
the Cα–Cβ bond. The catalysts
were also active for the oxidative cleavages of other lignin models
and oxidized organosolv lignin
Self-Assembly of a CsCl-like 3D Supramolecular Network from [Zn<sub>6</sub>(HL)<sub>6</sub>(H<sub>2</sub>L)<sub>6</sub>]<sup>6+</sup> Metallamacrocycles and (H<sub>2</sub>O)<sub>20</sub> Clusters (H<sub>2</sub>L = 4-(2-Pyridyl)-6-(4-pyridyl)-2-aminopyrimidine)
The reaction of Zn(NO3)2·6H2O with multifunctional ligand 4-(2-pyridyl)-6-(4-pyridyl)-2-aminopyrimidine (H2L) leads to a circular hexanuclear zinc complex [Zn6(HL)6(H2L)6](NO3)6·26H2O (1), confirmed by single-crystal X-ray diffraction. In the [Zn6(HL)6(H2L)6]6+ cation, six zinc centers are arranged in a chairlike conformation and 12 ligands fulfill bridging and terminal functions, respectively. The particular interest of complex 1 is the formation of a unique water cluster (H2O)26 composed of a clathrate (H2O)20 core and six dangling water molecules, and the clathrate (H2O)20 core is structurally similar to the famous “Bucky water” (H2O)20. Furthermore, the water molecules and the nitrate ions are assembled into an interesting negative three-dimensional (3D) framework through hydrogen bonds, and the [Zn6(HL)6(H2L)6]6+ cations just locate in the cavities of the anionic 3D network. To gain insight into the stability of (H2O)20 observed in complex 1, we isolate the water cluster from its environments and compare its stability with “Bucky water” (H2O)20 by a theoretical calculation method. Complex 1 displays room temperature photoluminescence
Controllable Assembly of Vanadium-Containing Polyoxoniobate-Based Three-Dimensional Organic–Inorganic Hybrid Compounds and Their Photocatalytic Properties
The
controllable synthesis of two vanadium-containing polyoxoniobate-based
three-dimensional organic–inorganic hybrid compounds, [Co(pn)<sub>2</sub>]<sub>4</sub>[HPNb<sub>10</sub>V<sup>IV</sup><sub>2</sub>O<sub>40</sub>(V<sup>IV</sup>O)<sub>4</sub>]·17H<sub>2</sub>O (<b>1</b>) and [Co(pn)<sub>2</sub>]<sub>5</sub>[PNb<sub>12</sub>O<sub>40</sub>(V<sup>IV</sup>O)<sub>6</sub>](OH)<sub>7</sub>·15H<sub>2</sub>O (<b>2</b>), where pn = 1,2-diaminopropane, is realized
by changing the hydrothermal temperature or adding <i>N</i>-(aminoethyl)piperazine as an additive. Both compounds <b>1</b> and <b>2</b> are structurally characterized by single-crystal/powder
X-ray diffraction and IR and X-ray photoelectron spectroscopy. Compound <b>1</b> features a new divanadium-substituted Keggin polyoxoniobate
capped by four vanadyl groups, and the polyanion in <b>2</b> exhibits the highest coordination number (10-connected) in polyoxoniobate
chemistry. Moreover, the photocatalytic activities of <b>1</b> and <b>2</b> for hydrogen evolution are preliminarily assessed
Synthesis and Pharmacokinetic Study of Three Gemfibrozil Salts: An Exploration of the Structure–Property Relationship
Three salts, [H<sub>3</sub>N(CH<sub>2</sub>)<sub>2</sub>NH<sub>3</sub>)][gem]<sub>2</sub> (<b>1</b>), [H<sub>3</sub>N(CH<sub>2</sub>)<sub>3</sub>NH<sub>3</sub>)][gem]<sub>2</sub>·2H<sub>2</sub>O (<b>2</b>),
and [H<sub>3</sub>N(CH<sub>2</sub>)<sub>4</sub>NH<sub>3</sub>)][gem]<sub>2</sub>·2H<sub>2</sub>O (<b>3</b>) of the minimally
soluble drug gmfibrozil
(Hgem), used for the treatment of hyperlipidemia have been synthesized
by using a series of diamine with different carbon chain lengths and
characterized by single crystal/powder X-ray diffraction, Fourier
transform infrared spectroscopy, and <sup>1</sup>H nuclear magnetic
resonance. In the three salts, two protons of two gmfibrozil molecules
transfer to one diamine, and the resulting organic diammonium cation
and gmfibrozil anion are assembled by hydrogen bond interactions into
a two-dimensional layer. Although the apparent solubility of salts <b>1</b>–<b>3</b> is obviously improved compared to
that of the original gemfibrozil, pharmacokinetic studies in rats
indicate the enhancement of absorption is limited with the relative
bioavailability of 104% for <b>1</b>, 154% for <b>2</b>, and 108% for <b>3</b>. It is notable that the rapid dissolution
behavior of salt <b>1</b>–<b>3</b> leads to the
increase of maximal plasma concentration (<i>C</i><sub>max</sub>) and the dramatic shortening of the time required to reach the <i>C</i><sub>max</sub>. The investigation of the structure–property
relationship shows that there is little correlation of solubility
with the carbon chain length of cation which is different from previous
observations, and we speculate that both electrostatic attraction
and hydrogen bond interaction contribute to the solubility order (<b>2</b> > <b>1</b> > <b>3</b>)
Structural Diversity of Diosgenin Hydrates: Effect of Initial Concentration, Water Volume Fraction, and Solvent on Crystallization
Four
hemihydrates (HH-I, HH-II, HH-III, and HH-IV) and two monohydrates
(MH-I, MH-II) of diosgenin, a steroid sapogenin, have been prepared.
Hydrates HH-I, HH-III, HH-IV, MH-I, and MH-II have been thoroughly
characterized by single-crystal X-ray diffraction, powder X-ray diffraction,
Fourier transform infrared spectroscopy, thermogravimetry, and differential
scanning calorimetry. Although in these cases diosgenin has a similar
conformation, hydrogen bonding interactions connect diosgenin and
the lattice water molecule into different supermolecular structures.
More importantly, three controlling factors, including initial concentration,
water volume fraction, and solvent, have been investigated in the
crystallization of diosgenin hydrates. The control experiments in
ethanol display that as the initial concentration increases, HH-III,
HH-I, and HH-II appear in order, and with the increase of water content,
HH-I, HH-III, MH-I, and MH-II are obtained correspondingly. When acetone
is used as solvent, HH-IV was synthesized. Moreover, we observed that
stick-like crystals of HH-III gradually transform to plate-like ones
of MH-I in solution at ambient conditions. This transformation is
prevented by lowering temperature and is accelerated by adding water
Sodium Salts and Solvate of Rebamipide: Synthesis, Structure, and Pharmacokinetic Study
Two
sodium salts (Na(CH<sub>3</sub>CH<sub>2</sub>OH) (HReb) (<b>1</b>) and Na<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>(Reb) (<b>2</b>)), one methanol solvate (H<sub>2</sub>Reb·CH<sub>3</sub>OH
(<b>3</b>)), and one methyl ester (<b>4</b>) of the
minimally soluble drug, rebamipide (H<sub>2</sub>Reb), used for the
treatment of gastric ulcers and gastritis have been synthesized. For
the first time the structure of rebamipide has been determined by
single crystal X-ray diffraction. Although salts <b>1</b> and <b>2</b> were prepared under the similar conditions, their structures
are different. In <b>1</b>, rebamipide loses the proton of the
carboxyl group to interact with the sodium ion, but in <b>2</b> the drug molecule converts to its prototropic tautomer and then
simultaneously loses the protons of the carboxyl and hydroxyl groups
to form salt. Control experiments show that reaction temperature is
the key factor influencing the formation of salts. Although all methanol
was used in the synthesis of <b>3</b> and <b>4</b>, in <b>3</b> methanol acts as solvent involved in the lattice, while
in <b>4</b> it reacts with rebamipide to form ester. By analyzing
the mass spectra of the reaction solution, we speculate that the crystallization
of <b>3</b> and <b>4</b> is controlled by the product’s
solubility. Dissolution studies indicate that both the maximum solubility
and dissolution rate of <b>1</b>–<b>4</b> in simulated
succus gastricus are improved. Furthermore, pharmacokinetic behavior
of compounds <b>1</b>–<b>4</b> was investigated
in rats and the results indicate that the bioavailability of <b>1</b>, <b>3</b>, and <b>4</b> upon oral administration
is enhanced compared to that of API
Three Candesartan Salts with Enhanced Oral Bioavailability
Three new salts, [H<sub>3</sub>N(CH<sub>2</sub>)<sub>2</sub>NH<sub>3</sub>][can]·2H<sub>2</sub>O (<b>1</b>), [H<sub>3</sub>N(CH<sub>2</sub>)<sub>3</sub>NH<sub>3</sub>][can]·2H<sub>2</sub>O (<b>2</b>), and [NH<sub>4</sub>][Hcan] (<b>3</b>),
of the minimally soluble antihypertensive drug, Candesartan (H<sub>2</sub>can), have been prepared by solvent-assisted grinding. Salts <b>1–3</b> also have been thoroughly characterized by single-crystal
X-ray diffraction, powder X-ray diffraction, Fourier transform infrared
spectroscopy, <sup>1</sup>H nuclear magnetic resonance, thermogravimetry,
and differential scanning calorimetry. In the case of <b>1</b> and <b>2</b>, two protons of carboxyl and tetrazole groups
of Candesartan transfer to the diamine, resulting in salts where both
hydrogen bonding and electrostatic interactions that link the Candesartan
and diamine (diammonium) units into a one-dimensional supramolecular
ribbon. However, unlike the case in <b>1</b> and <b>2</b>, only one proton from the carboxyl group of Candesartan transfers
to ammonia in <b>3</b> and ionic components now assemble into
a three-dimensional supramolecular network. Dissolution studies indicate
that both the apparent solubility and dissolution rate of salts <b>2</b> and <b>3</b> in phosphate buffer are dramatically
improved compared to those of the original active pharmaceutical ingredient
(API). Furthermore, to evaluate the absorption effect of salts <b>1–3</b> <i>in vivo</i>, pharmacokinetic studies
were performed in rats. It is notable that the oral bioavailability
of salts <b>1–3</b> is enhanced by 1.3, 2.5, and 3.1
times, respectively, compared to that of the API
Cu-based Polyoxometalate Catalyst for Efficient Catalytic Hydrogen Evolution
Copper-based complexes have been
largely neglected as potential water reduction catalysts. This article
reports the synthesis and characterization of a tetra-copper-containing
polyoxotungstate, Na3K7[Cu4(H2O)2(B-α-PW9O34)2]·30H2O (Na3K7-Cu4P2). Cu4P2 is a water-compatible catalyst
for efficient visible-light-driven hydrogen evolution when coupled
to (4,4′-di-tert-butyl-2,2′-dipyridyl)-bis(2-phenylpyridine(1H))-iridium(III) hexafluorophosphate ([Ir(ppy)2(dtbbpy)][PF6]) as a light absorber and triethanolamine
(TEOA) as sacrificial electron donor. Under minimally optimized conditions,
a turnover number (TON) of ∼1270 per Cu4P2 catalyst is
obtained after 5 h of irradiation (light-emitting diode; λ =
455 nm; 20 mW); a photochemical quantum efficiency of as high as 15.9%
is achieved. Both oxidative and reductive quenching pathways are observed
by measuring the luminescence intensity of excited state [Ir(ppy)2(dtbbpy)]+* in the presence of Cu4P2 or TEOA,
respectively. Many stability studies (e.g., UV–vis absorption,
FT-IR, dynamic light scattering, transmission electron microscopy,
and scanning electron microscopy/energy-dispersive X-ray spectroscopy)
show that catalyst Cu4P2 undergoes slow decomposition under turnover
conditions; however, both the starting Cu4P2 as well as its molecular
decomposition products are the dominant catalytically active species
for H2 evolution not Cu or CuOx particles. Considering the high abundance and low cost of copper,
the present work provides considerations for the design and synthesis
of efficient, molecular, water-compatible Cu-based water reduction
catalysts
